알레르기성 비염 치료 시장 : 치료 유형별, 투여 경로별, 유통 채널별, 지역별
Allergic Rhinitis Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography
상품코드
:
1672756
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 알레르기성 비염 치료 시장은 2025년에는 169억 1,000만 달러로 추정되며, 2032년에는 238억 1,000만 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 5.0%로 성장할 전망입니다.
| 리포트 범위 |
리포트 상세 |
| 기준연도 |
2024 |
2025년 시장 규모 |
169억 1,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR : |
5.00% |
2032년 가치 예측 |
238억 1,000만 달러 |
도표. 알레르기성 비염 치료 시장 점유율(%), 2025년 지역별
일반적으로 꽃가루 알레르기로 알려진 알레르기성 비염은 꽃가루나 먼지 등 공기 중에 떠다니는 하나 이상의 알레르겐에 대해 신체가 염증 반응을 보이는 질환입니다. 재채기, 콧물, 코막힘, 눈 가려움증 등의 증상을 유발합니다. 알레르기성 비염의 전 세계 유병률은 환경오염 증가와 생활습관의 변화 등의 요인으로 인해 최근 수년간 꾸준히 증가하고 있습니다. 한 추정에 따르면 현재 전 세계 인구의 약 10-30%가 알레르기성 비염을 앓고 있으며, 건강상의 큰 문제로 대두되고 있습니다. 알레르기 비염에 대한 인식이 높아지고 진단이 개선됨에 따라 알레르기 비염 치료제 시장도 크게 확대되고 있습니다.
시장 역학:
세계 알레르기 비염 치료제 시장은 전 세계 알레르기 비염 환자의 유병률 증가에 의해 주도되고 있습니다. 또한 환경 오염 수준 증가와 기후 패턴의 변화로 인해 꽃가루와 같은 공기 중 알레르겐이 증가함에 따라 시장은 견고한 성장세를 보이고 있습니다. 진단 및 치료법의 발전과 더불어 제약회사들의 알레르기 연구에 대한 투자 확대는 신제품 출시로 이어져 시장 성장을 촉진하고 있습니다. 그러나 블록버스터 의약품 브랜드의 특허 만료와 제네릭 의약품의 출시 가능성은 혁신적 제약사의 성장을 어느 정도 저해할 것으로 예상됩니다. 그럼에도 불구하고 인도와 중국과 같은 신흥 국가들은 향후 수년간 엄청난 인구와 알레르기를 앓고 있는 인구가 많은 신흥 국가들은 시장 기업에게 유리한 기회를 제공할 것으로 보입니다.
본 조사의 주요 특징
- 세계의 알레르기성 비염 치료제 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한 다양한 부문에 걸친 잠재적인 매출 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 세계 알레르기성 비염 치료제 시장의 주요 기업을 기업 소개, 제품 포트폴리오, 주요 특징, 주요 성과, 전략 등의 매개 변수를 기반으로 프로파일링합니다.
- 주요 기업은 Merck &Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson &Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Regeneron Pharmaceuticals Inc., Revolo Biotherapeutics, Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Bayer AG, Alembic Pharmaceuticals Limited, Sanofi, Hikma Pharmaceuticals PLC 등입니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 알레르기 비염 치료제 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 알레르기 비염 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 리포트 설명
- 개요
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 주요 발전
- 규제 시나리오
- 파이프라인 분석
- 역학
- 인수와 제휴 시나리오
- 제품 발매/승인
- 브랜드와 가격 분석
- 자금조달과 투자
- PEST 분석
- Porter의 산업 분석
제4장 세계의 알레르기성 비염 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 구상
- 시장에 대한 COVID-19의 영향
제5장 세계의 알레르기성 비염 치료 시장, 치료 유형별, 2020-2032년, (10억 달러)
- 면역치료
- 피하 면역치료(SCIT)
- 설하 면역치료(SLIT)
- 항히스타민약
- 충혈 제거약
- 류코트리엔 수용체 길항제
- 코르티코스테로이드
- 기타
제6장 세계의 알레르기성 비염 치료 시장, 투여 경로별, 2020-2032년, (10억 달러)
제7장 세계의 알레르기성 비염 치료 시장, 유통 채널별, 2020-2032년, (10억 달러)
제8장 세계의 알레르기성 비염 치료 시장, 지역별, 2020-2032년, (10억 달러)
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- 기업 개요
- Merck &Co., Inc.
- Boehringer Ingelheim International GmbH
- AstraZeneca
- GSK plc.
- Johnson &Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan NV
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Dr. Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC
제10장 애널리스트의 시점
제11장 참고 문헌과 조사 방법
KSA
영문 목차
Global Allergic Rhinitis Treatment Market is estimated to be valued at USD 16.91 Bn in 2025 and is expected to reach USD 23.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 16.91 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
5.00% |
2032 Value Projection: |
USD 23.81 Bn |
Figure. Allergic Rhinitis Treatment Market Share (%), By Region 2025
Allergic rhinitis, commonly known as hay fever, is a condition where the body exhibits an inflammatory response to one or more airborne allergens like pollen or dust. It causes symptoms like sneezing, runny nose, nasal congestion and itchy eyes. The global prevalence of allergic rhinitis has been steadily increasing in recent years due to factors like increasing environmental pollution and changes in lifestyle. According to some estimates, about 10-30% of the global population currently suffers from allergic rhinitis, making it a major health concern. With growing awareness and better diagnosis, the market for drugs to treat allergic rhinitis has also expanded significantly.
Market Dynamics:
The global allergic rhinitis treatment market is driven by the rising prevalence of allergic rhinitis cases globally. The market has also witnessed robust growth due to the increasing environmental pollution levels and changing climate patterns which have led to the proliferation of airborne allergens like pollen. Advancements in diagnosis and treatment options along with higher investments in allergy research by pharmaceutical companies are translating into new product launches and boosting the market growth. However, patent expiries of blockbuster drug brands coupled with the availability of generic alternatives are expected to hamper the growth of innovator drug makers to some extent. Nevertheless, emerging economies like India and China with their huge population base suffering from allergies present lucrative opportunities for market players in the coming years.
Key Features of the Study:
- This report provides an in-depth analysis of the global allergic rhinitis treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global allergic rhinitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Regeneron Pharmaceuticals Inc., Revolo Biotherapeutics, Dr. Reddy's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Bayer AG, Alembic Pharmaceuticals Limited, Sanofi, Hikma Pharmaceuticals PLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global allergic rhinitis treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market.
Detailed Segmentation-
- By Treatment Type:
- Immunotherapy
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-lingual Immunotherapy (SLIT)
- Anti-histamines
- Decongestants
- Leukotriene Receptor Antagonists
- Corticosteroids
- Others
- By Route of Administration:
- Oral
- Nasal
- Intraocular
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- AstraZeneca
- GSK plc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Brand and Pricing Analysis
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Allergic Rhinitis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-lingual Immunotherapy (SLIT)
- Anti-histamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Decongestants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Leukotriene Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intraocular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- E-commerce
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Allergic Rhinitis Treatment Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Dr. Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
